Analysis by Application (Platelet Function Disorder, Hemophilia, Thrombocytopenia, and Perioperative Indication); by Platelet (Whole Blood Derived Platelets, and Apheresis Derived Platelets); and by End User (Hospitals, Ambulatory Surgical Centers, and Other End Users) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2035
Buy Now
The global blood platelets market is estimated to garner a revenue of nearly USD 7 Billion by the end of 2035 by growing at a CAGR of ~5% over the forecast period, i.e., 2023 – 2035. Further, the market generated a revenue of around USD 5 Billion in the year 2022. The growth of the market can be attributed to the increasing number of blood-related disorders that increase the need for healthy blood and frequent blood transfusions. Furthermore, according to the World Health Organization, the sickle cell anemia patient requires blood transfusions every 4-6 weeks for an extended period of time. Moreover, anemia affects 42% of children under the age of five and 40% of pregnant women globally, according to data from the World Health Organization.
In addition to these, factors that are believed to fuel the market growth of blood platelets include the rising need for blood donation all across the world. In the United States, around 21 million blood components are transfused annually. On the other hand, the market growth is also attributed to the rise in the number of surgeries been carried out, followed by higher incidences of road accidents. Around 310 million major procedures are carried out annually in the world, with between 40 to 50 million taking place in the USA and 20 million in Europe. Additionally, surgery is needed to treat almost 11% of diseases worldwide. Furthermore, a vehicle crash or being hit by a vehicle claims the lives of almost 3,700 individuals per day. Moreover, in the United States, there were more than 6 million car accidents as of 2022.
|
Base Year |
2022 |
|
Forecast Year |
2023-2035 |
|
CAGR |
~5% |
|
Base Year Market Size (2022) |
~ USD 5 Billion |
|
Forecast Year Market Size (2035) |
~ USD 7 Billion |
|
Regional Scope |
|
Growth Drivers
Rising Number of Surgical Procedures – Surgeries often required the need of blood transfusions. Around 2 million surgical procedures were carried out in 2018, according to the WHO. Also, during the next five years, there will be a 30% increase in the number of surgical burden cases.
Growing Incidences of Organ Transplantation – Organ transplantation is only performed after matching the blood type, and also increases the need for transfusions. Chronic kidney disease (CKD), affects 10% of the population, claims millions of lives every year. Today, more than 2 million individuals throughout the world depend on dialysis or a kidney transplant for survival. Moreover, in the United Kingdom, there are around 6,721 patients on the organ transplant waiting list.
Rising Awareness Regarding Blood Donation – Higher blood donation is expected to drive the market’s growth. Blood to be transfused is first analyzed with the help of blood transfusion diagnostics. Therefore, it is anticipated to boost the growth of the market in the upcoming years. There are 118.5 million donated blood units collected annually worldwide, considering more would need to be collected to provide for everyone who needs transfusions.
Rise in the Number of Trauma Injuries– Road accidents sometimes lead to serious injuries, which are further treated by surgery. As per figures from the World Health Organization, traffic accidents kill around 1.3 million people annually around the world and are the leading cause of death for children and young adults between the ages of 5 and 29.
Challenges
The global blood platelets market is segmented and analyzed for demand and supply by application into platelet function disorder, hemophilia, thrombocytopenia, and perioperative indication. Out of the four application of blood platelet, the hemophilia segment is estimated to gain the largest market share over the projected time frame. The growth of the segment can be attributed to the increasing prevalence of hemophilia. Hemophilia, as it prevents the blood from clotting. Blood platelets and small protein biomolecules that are clotting factors in the body work together to produce a clot during the clotting process. Hemophilia affected roughly 210,000 people worldwide in 2020. In addition to this, In the United States, hemophilia was identified in about 18,400 people in 2021. Moreover, another 10,000 people struggle with additional bleeding diseases.
The global blood platelets market is also segmented and analyzed for demand and supply by end-user into hospitals, ambulatory surgical centers, and other end users. Amongst these three segments, the hospital segment is expected to garner a significant share. The growth of this segment is primarily attributed to the rise in the number of hospitals across the world. Every day, myriad of road traffic accidents, people in need of surgeries, and cases of blood transfusion are admitted to the hospitals. There are about 6000 hospitals in the United States, about 2000 in the United Kingdom, and over 11,000 in China.
Our in-depth analysis of the global blood platelets market includes the following segments:
|
By Application |
|
|
By Platelet |
|
|
By End User |
|
The North American blood platelets market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035. The growth of the market in the region can be attributed majorly to the rising need for blood transfusions and the higher count of blood donations. In America, more than 4 million individuals are anticipated to need blood transfusions each year, and each day, approximately 43,000 pints of blood are donated in the combined regions of the United States and Canada. Besides this, the rising incidences of surgical procedures and growing demand for transplantation, such as kidney, heart, knees, liver, corneal implants, and others, are also expected to boost the market growth in the region. Heart disease is the leading cause of death for both men and women in the US. Each year, around 500,000 open heart surgeries are performed. Also, there are currently close to 121,000 kidney transplant candidates in the United States.
The Asia Pacific blood platelets market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035. The market growth in the region is primarily ascribed to rise in the number of surgeries and growing need for organ transplantation. Around 25,000–30,000 people in India require liver transplants, while 50,000 people experience heart attacks each year. Moreover, over 150,000 knee surgeries are performed annually in India. On the other hand, the higher number of blood donations is also anticipated to propel the market growth in Asia Pacific region. Despite the COVID-19 pandemic's effects, around 16 million blood donations were made in China last year in 2019. Moreover, blood donations in China grew more than 40 times between 1998 and 2020. In China, there were nearly 5 million blood donations registered from January to April of 2022.
In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.
Ans: Increasing incidences of road accidents, rising cases in need of surgeries, and increasing need of blood donation and transfusion are the major factors driving the market growth.
Ans: The market is anticipated to attain a CAGR of ~5% over the forecast period, i.e., 2023 – 2035.
Ans: Risk of infection caused by transfusion, expensive treatment and accidents causes during blood transfusion are estimated to be the growth hindering factors for the market expansion.
Ans: The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Ans: The major players in the market are Sysmex Corporation, Haemochrom Diagnostica GmbH, Eurobio Scientific, LABiTec LAbor BioMedical Technologies GmbH, Thermo Fisher Scientific Inc., Terumo Corporation, PerkinElmer Inc., Werfen, S.A., F. Hoffmann-La Roche Ltd., and Aggredyne, Inc.
Ans: The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.
Ans: The market is segmented by application, platelet, end user, and by region.
Ans: The hemophilia segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Submit Your Request For Proposal (RFP)
